Caxton Associates (New York)’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	$498K	Hold	16,557	–	–	0.02%	328
2024 Q3	$387K	Buy	+16,557	New	+$387K	0.01%	400
2022 Q3	–	Sell	-68,677	Closed	-$292K	–	648
2022 Q2	$292K	Buy	+68,677	New	+$292K	0.03%	378